Effect of oat intake on glycaemic control and insulin sensitivity: A meta-analysis of randomised controlled trials

British Journal of Nutrition

Volumn 112, Issue 3, 2014, Pages 457-466

  Bao, Lei ^a   Cai, Xiaxia ^a   Xu, Meihong ^a   Li, Yong ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Glycaemic control; Meta analyses; Oats; Type 2 diabetes mellitus; Glucan

Indexed keywords

BETA GLUCAN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN;

ARTICLE; DIETARY INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL ASSESSMENT; OAT; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT DURATION;

AVENA;

AVENA SATIVA; BLOOD GLUCOSE; DIET; FASTING; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84903778968     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514000889     Document Type: Article

References (46)

1. Danaei G, Finucane MM, Lu Y, et al. (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378, 31-40.
2. Shaw JE, Sicree RA & Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87, 4-14.
3. Rathmann W & Giani G (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 2568-2569. (Pubitemid 39281428)
4. The Diabetes Control and Complications Trial Research Group (1995) The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 122, 561-568.
5. Nathan DM, Cleary PA, Backlund JY, et al. (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353, 2643-2653. (Pubitemid 41817713)
6. Li G, Zhang P, Wang J, et al. (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371, 1783-1789. (Pubitemid 351697954)
7. Ramachandran A, Snehalatha C, Mary S, et al. (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49, 289-297. (Pubitemid 43185397)
8. Sadiq Butt M, Tahir-Nadeem M, Khan MK, et al. (2008) Oat: unique among the cereals. Eur J Nutr 47, 68-79.
9. Haboubi NY, Taylor S & Jones S (2006) Coeliac disease and oats: a systematic review. Postgrad Med J 82, 672-678. (Pubitemid 44786875)
10. Battilana P, Ornstein K, Minehira K, et al. (2001) Mechanisms of action of beta-glucan in postprandial glucose metabolism in healthy men. Eur J Clin Nutr 55, 327-333. (Pubitemid 32396741)
11. Tappy L, Gu?golz E & Wu?rsch P (1996) Effects of breakfast cereals containing various amounts of beta-glucan fibers on plasma glucose and insulin responses in NIDDM subjects. Diabetes Care 19, 831-834. (Pubitemid 26286988)
12. Tapola N, Karvonen H, Niskanen L, et al. (2005) Glycemic responses of oat bran products in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 15, 255-261. (Pubitemid 41190982)
13. Pick ME, Hawrysh ZJ, Gee MI, et al. (1996) Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J Am Diet Assoc 96, 1254-1261. (Pubitemid 27381748)
14. Nazare JA, Normand S, Oste Triantafyllou A, et al. (2009) Modulation of the postprandial phase by beta-glucan in overweight subjects: effects on glucose and insulin kinetics. Mol Nutr Food Res 53, 361-369.
15. Beck EJ, Tapsell LC, Batterham MJ, et al. (2010) Oat betaglucan supplementation does not enhance the effectiveness of an energy-restricted diet in overweight women. Br J Nutr 103, 1212-1222.
16. Braaten JT, Wood PJ, Scott FW, et al. (1991) Oat gum, a soluble fiber which lowers glucose and insulin in normal individuals after an oral glucose load: comparison with guar gum. Am J Clin Nutr 53, 1425-1430.
17. Panahi S, Ezatagha A, Temelli F, et al. (2007) b-Glucan from two sources of oat concentrates affect postprandial glycemia in relation to the level of viscosity. J Am Coll Nutr 26, 639-644.
18. Liljeberg HG, Granfeldt YE & Bjo?rck IM (1996) Products based on a high fiber barley genotype, but not on common barley or oats, lower postprandial glucose and insulin responses in healthy humans. J Nutr 126, 458-466. (Pubitemid 26055776)
19. McGeoch SC, Johnstone AM, Lobley GE, et al. (2013) A randomized crossover study to assess the effect of an oat-rich diet on glycaemic control, plasma lipids and postprandial glycaemia, inflammation and oxidative stress in Type 2 diabetes. Diabet Med 30, 1314-1323.
20. Cugnet-Anceau C, Nazare JA, Biorklund M, et al. (2010) A controlled study of consumption of beta-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects. Br J Nutr 103, 422-428.
21. Biorklund M, Holm J & Onning G (2008) Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal. Ann Nutr Metab 52, 83-90. (Pubitemid 351723129)
22. Oremus M, Wolfson C, Perrault A, et al. (2001) Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials. Dement Geriatr Cogn Disord 12, 232-236. (Pubitemid 32217854)
23. Whitehead A (2002) Meta-analysis of Controlled Clinical Trials. pp. 60-1204. Chichester: John Wiley & Sons.
24. Higgins JP, Thompson SG, Deeks JJ, et al. (2003) Measuring inconsistency in meta-analyses. BMJ 327, 557-560. (Pubitemid 37088507)
25. Egger M, Davey SG, Schneider M, et al. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634. (Pubitemid 27387172)
26. Saltzman E, Das SK, Lichtenstein AH, et al. (2001) An oatcontaining hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women. J Nutr 131, 1465-1470. (Pubitemid 32422968)
27. Davy BM, Davy KP, Ho RC, et al. (2002) High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middleaged and older men. Am J Clin Nutr 76, 351-358. (Pubitemid 34804056)
28. Biorklund M, van Rees A, Mensink RP, et al. (2005) Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with beta-glucans from oats or barley: a randomised dose-controlled trial. Eur J Clin Nutr 59, 1272-1281. (Pubitemid 41655632)
29. Maki KC, Galant R, Samuel P, et al. (2007) Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure. Eur J Clin Nutr 61, 786-795. (Pubitemid 47232358)
30. Queenan KM, Stewart ML, Smith KN, et al. (2007) Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 6, 6.
31. Reyna-Villasmil N, Bermudez-Pirela V, Mengual-Moreno E, et al. (2007) Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia. Am J Ther 14, 203-212. (Pubitemid 46597661)
32. Granfeldt Y, Nyberg L & Bjorck I (2008) Muesli with 4 g oat beta-glucans lowers glucose and insulin responses after a bread meal in healthy subjects. Eur J Clin Nutr 62, 600-607. (Pubitemid 351663399)
33. Liatis S, Tsapogas P, Chala E, et al. (2009) The consumption of bread enriched with betaglucan reduces LDL-cholesterol and improves insulin resistance in patients with type 2 diabetes. Diabetes Metab 35, 115-120.
34. Juvonen KR, Salmenkallio-Marttila M, Lyly M, et al. (2011) Semisolid meal enriched in oat bran decreases plasma glucose and insulin levels, but does not change gastrointestinal peptide responses or short-term appetite in healthy subjects. Nutr Metab Cardiovasc Dis 21, 748-756.
35. Zhang PP, Hu XZ, Zhen HM, et al. (2012) Oat b-glucan increased ATPases activity and energy charge in small intestine of rats. J Agric Food Chem 60, 9822-9827.
36. Hlebowicz J (2009) Postprandial blood glucose response in relation to gastric emptying and satiety in healthy subjects. Appetite 53, 249-252.
37. Behall KM, Scholfield DJ, Hallfrisch JG, et al. (2006) Consumption of both resistant starch and beta-glucan improves postprandial plasma glucose and insulin in women. Diabetes Care 29, 975-981.
38. Drzikova B, Dongowski G & Gebhardt E (2005) Dietary fibre-rich oat-based products affect serum lipids, microbiota, formation of short-chain fatty acids and steriods in rats. Br J Nutr 94, 1012-1025. (Pubitemid 43092436)
39. Lv N, Song MY, Lee YR, et al. (2009) Dihydroavenanthramide D protects pancreatic beta-cells from cytokine and streptozotocin toxicity. Biochem Biophys Res Commun 387, 97-102.
40. Ren Y, Yang X, Niu X, et al. (2011) Chemical characterization of the avenanthramide-rich extract from oat and its effect on D-galactose-induced oxidative stress in mice. J Agric Food Chem 59, 206-211.
41. Choi JS, Kim H, Jung MH, et al. (2010) Consumption of barley beta-glucan ameliorates fatty liver and insulin resistance in mice fed a high-fat diet. Mol Nutr Food Res 54, 1004-1013.
42. Shen RL, Cai FL, Dong JL, et al. (2011) Hypoglycemic effects and biochemical mechanisms of oat products on streptozotocin-induced diabetic mice. J Agric Food Chem 59, 8895-8900.
43. Tiwari U & Cummins E (2011) Meta-analysis of the effect of b-glucan intake on blood cholesterol and glucose levels. Nutrition 27, 1008-1016.
44. Shewry PR, Piironen V, Lampi AM, et al. (2008) Phytochemical and fiber components in oat varieties in the HEALTHGRAIN Diversity Screen. J Agric Food Chem 56, 9777-9784.
45. Andersson AA, Lampi AM, Nystro?m L, et al. (2008) Phytochemical and fiber components in barley varieties in the HEALTHGRAIN Diversity Screen. J Agric Food Chem 56, 9767-9776.
46. Ma X, Gu J, Zhang Z, et al. (2013) Effects of Avena nuda L. on metabolic control and cardiovascular disease risk among Chinese patients with diabetes and meeting metabolic syndrome criteria: secondary analysis of a randomized clinical trial. Eur J Clin Nutr 67, 1291-1297.